OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model
Luíz M. Oliveira, Bárbara Falquetto, Thiago S. Moreira, et al.
Experimental Neurology (2018) Vol. 309, pp. 107-118
Closed Access | Times Cited: 25

Showing 25 citing articles:

Respiratory disorders of Parkinson’s disease
Yasmin C. Aquino, Laís M. Cabral, Nicole C. Miranda, et al.
Journal of Neurophysiology (2021) Vol. 127, Iss. 1, pp. 1-15
Closed Access | Times Cited: 38

A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms
Débora Masini, Carina Plewnia, Maëlle Bertho, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 598-598
Open Access | Times Cited: 35

Challenges and Opportunities in Exploring Non‐Motor Symptoms in 6‐Hydroxydopamine Models of Parkinson's Disease: A Systematic Review
Mateus Rodrigues, Barbara Schweizer, C. Gomes, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 2
Open Access

Etiologies of insomnia in Parkinson's disease – Lessons from human studies and animal models
Aviv D. Mizrahi-Kliger, Lucia K. Feldmann, Andrea A. Kühn, et al.
Experimental Neurology (2022) Vol. 350, pp. 113976-113976
Open Access | Times Cited: 21

A systematic review and meta‐analysis of respiratory dysfunction in Parkinson's disease
Laura McMahon, Catherine Blake, Olive Lennon
European Journal of Neurology (2023) Vol. 30, Iss. 5, pp. 1481-1504
Open Access | Times Cited: 12

Sleep Disorders in Rodent Models of Parkinson’s Disease
Daniel de Castro Medeiros, Cleiton Lopes‐Aguiar, Márcio Flávio Dutra Moraes, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 31

The role of orexin in Parkinson's disease
Alisha Braun, Jim Manavis, Akihiro Yamanaka, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Open Access | Times Cited: 3

Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25

The retrotrapezoid nucleus and the neuromodulation of breathing
Thiago S. Moreira, Cleyton R. Sobrinho, Bárbara Falquetto, et al.
Journal of Neurophysiology (2020) Vol. 125, Iss. 3, pp. 699-719
Open Access | Times Cited: 21

Orexin in Respiratory and Autonomic Regulation, Health and Diseases
Savannah Barnett, Aihua Li
Comprehensive physiology (2020), pp. 345-363
Closed Access | Times Cited: 20

Respiratory Function and Dysfunction in Parkinson-Type Neurodegeneration
Michal Pokusa, Dominika Hajdúchová, T. Budaj, et al.
Physiological Research (2020), pp. S69-S79
Open Access | Times Cited: 20

Association of Cognitive Deficit with Glutamate and Insulin Signaling in a Rat Model of Parkinson’s Disease
Ana Knezović, Marija Piknjac, Jelena Osmanović Barilar, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 683-683
Open Access | Times Cited: 5

Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model
Luíz M. Oliveira, Elisandra Henrique, Isabella B. Bustelli, et al.
Experimental Neurology (2019) Vol. 323, pp. 113110-113110
Closed Access | Times Cited: 14

Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience
Alexey P. Bolshakov, M. Yu. Stepanichev, Yulia V. Dobryakova, et al.
Toxins (2020) Vol. 12, Iss. 9, pp. 546-546
Open Access | Times Cited: 14

Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
Sachin Kumar, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2141-2153
Closed Access | Times Cited: 12

Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12

State-dependent alteration of respiration in a rat model of Parkinson's disease
Jean Jacques Walker, Estelle Meunier, Samuel Garcia, et al.
Experimental Neurology (2024) Vol. 375, pp. 114740-114740
Open Access | Times Cited: 1

Regulation of blood vessels by ATP in the ventral medullary surface in a rat model of Parkinson’s disease
Luíz M. Oliveira, Silvio A. Fernandes‐Junior, Laís M. Cabral, et al.
Brain Research Bulletin (2022) Vol. 187, pp. 138-154
Open Access | Times Cited: 4

Update on vascular control of central chemoreceptors
Thiago S. Moreira, Daniel K. Mulkey, Ana C. Takakura
Experimental Physiology (2023) Vol. 109, Iss. 11, pp. 1837-1843
Open Access | Times Cited: 2

Inhibition of anandamide hydrolysis does not rescue respiratory abnormalities observed in an animal model of Parkinson's disease
Luara A. Batista, Laís M. Cabral, Thiago S. Moreira, et al.
Experimental Physiology (2021) Vol. 107, Iss. 2, pp. 161-174
Open Access | Times Cited: 1

Orexin in Respiratory and Autonomic Regulation, Health and Diseases
Savannah Barnett, Aihua Li
Comprehensive physiology (2020) Vol. 10, Iss. 2, pp. 345-363
Closed Access

Page 1

Scroll to top